Az angiotenzin II-receptor-gátlás elméleti háttere és klinikofarmakológiai sajátosságai.

Translated title of the contribution: Theoretical background of angiotensin II receptor blockade and its features in clinical pharmacology

G. Winkler, G. Jermendy, Lajos Matos

Research output: Contribution to journalArticle

Abstract

The angiotensin (II) receptor (1) blockers are known first of all as antihypertensive drugs, however, due to the role of the tissue renin-angiotensin system (RAS) in different pathological conditions, their clinical importance became more pronounced and are at present more widely used. The article gives an overview of the recent knowledge in this field. Beside of summarizing physiological and the most important pathophysiological aspects of the RAS, as well as pharmacokinetic properties of the different angiotensin receptor blocker drugs used at present in Hungary, the potential differences in blocking of the converting enzyme and the angiotensin II receptors are also reviewed.

Original languageHungarian
Pages (from-to)1763-1768
Number of pages6
JournalOrvosi Hetilap
Volume144
Issue number36
Publication statusPublished - Sep 7 2003

Fingerprint

Angiotensin Receptors
Clinical Pharmacology
Angiotensin Receptor Antagonists
Renin-Angiotensin System
Hungary
Antihypertensive Agents
Pharmacokinetics
Enzymes
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Az angiotenzin II-receptor-gátlás elméleti háttere és klinikofarmakológiai sajátosságai. / Winkler, G.; Jermendy, G.; Matos, Lajos.

In: Orvosi Hetilap, Vol. 144, No. 36, 07.09.2003, p. 1763-1768.

Research output: Contribution to journalArticle

@article{67831faccf8042ee8dea0ab6579942c0,
title = "Az angiotenzin II-receptor-g{\'a}tl{\'a}s elm{\'e}leti h{\'a}ttere {\'e}s klinikofarmakol{\'o}giai saj{\'a}toss{\'a}gai.",
abstract = "The angiotensin (II) receptor (1) blockers are known first of all as antihypertensive drugs, however, due to the role of the tissue renin-angiotensin system (RAS) in different pathological conditions, their clinical importance became more pronounced and are at present more widely used. The article gives an overview of the recent knowledge in this field. Beside of summarizing physiological and the most important pathophysiological aspects of the RAS, as well as pharmacokinetic properties of the different angiotensin receptor blocker drugs used at present in Hungary, the potential differences in blocking of the converting enzyme and the angiotensin II receptors are also reviewed.",
author = "G. Winkler and G. Jermendy and Lajos Matos",
year = "2003",
month = "9",
day = "7",
language = "Hungarian",
volume = "144",
pages = "1763--1768",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "36",

}

TY - JOUR

T1 - Az angiotenzin II-receptor-gátlás elméleti háttere és klinikofarmakológiai sajátosságai.

AU - Winkler, G.

AU - Jermendy, G.

AU - Matos, Lajos

PY - 2003/9/7

Y1 - 2003/9/7

N2 - The angiotensin (II) receptor (1) blockers are known first of all as antihypertensive drugs, however, due to the role of the tissue renin-angiotensin system (RAS) in different pathological conditions, their clinical importance became more pronounced and are at present more widely used. The article gives an overview of the recent knowledge in this field. Beside of summarizing physiological and the most important pathophysiological aspects of the RAS, as well as pharmacokinetic properties of the different angiotensin receptor blocker drugs used at present in Hungary, the potential differences in blocking of the converting enzyme and the angiotensin II receptors are also reviewed.

AB - The angiotensin (II) receptor (1) blockers are known first of all as antihypertensive drugs, however, due to the role of the tissue renin-angiotensin system (RAS) in different pathological conditions, their clinical importance became more pronounced and are at present more widely used. The article gives an overview of the recent knowledge in this field. Beside of summarizing physiological and the most important pathophysiological aspects of the RAS, as well as pharmacokinetic properties of the different angiotensin receptor blocker drugs used at present in Hungary, the potential differences in blocking of the converting enzyme and the angiotensin II receptors are also reviewed.

UR - http://www.scopus.com/inward/record.url?scp=0642335213&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0642335213&partnerID=8YFLogxK

M3 - Article

VL - 144

SP - 1763

EP - 1768

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 36

ER -